ArticleCancer diagnosis & prognosis

Five-year Disease Control With Alectinib in a Patient With Metastatic ALK-rearranged Lung Adenocarcinoma.

Gen Ohara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.